Author:
Arjun Chanda,Mukherjee Archana,Bhatt Jyotsna,Chaudhari Pradip,Repaka Krishna Mohan,Venkatesh Meera,Samuel Grace
Funder
Dr. A Kohli, Chief Executive, BRIT, Navi Mumbai
Reference17 articles.
1. Antimicrobial peptide 99mTc-UBI (29-41) ubiquicidin 29-41 as human infection-imaging agent: clinical trial;Akhtar;J. Nucl. Med.,2005
2. Clinical trial of specific imaging of infections;Arteaga de Murphy;Nucl. Med. Commun.,2010
3. 99mTc-Ubiquicidin [29-41], a promising radiopharmaceutical to differentiate orthopedic implant infections from sterile inflammation;Beikia;Iran. J. Pharm. Res.,2013
4. Synthetic peptides derived from human antimicrobial peptide ubiquicidin accumulate at sites of infections and eradicate (multi-drug resistant) Staphylococcus aureus in mice;Brouwer;Peptides,2006
5. Kit for instant Tc-99m labeling of the antimicrobial peptide ubiquicidin 29-41;Ferro-Flores;J. Radioanal. Nucl. Chem.,2005
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献